Skip to content

MiMedx Group MDXG Work in process

Work in process at other companies

IAR
Integra LifeSciencesIART
$109.68M+18.4%
Artivion logo
ArtivionAORT
$20.4M+25.3%
Solventum logo
SolventumSOLV
$222M+29.8%
Vericel logo
VericelVCEL
$1.51M-5.0%
Enovis logo
EnovisENOV
$59.47M+19.7%
CorMedix logo
CorMedixCRMD
$9.23M+115%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's work in process?
MiMedx Group (MDXG) reported work in process of $4.22M in Q1 2026.
How has MiMedx Group's work in process changed year-over-year?
MiMedx Group's work in process decreased by 6.7% year-over-year, from $4.53M to $4.22M.
What is the long-term trend for MiMedx Group's work in process?
Over 5 years (2020 to 2025), MiMedx Group's work in process has grown at a 15.0% compound annual growth rate (CAGR), from $4.32M to $8.67M.
What does work in process mean?
Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.